Oncoloxía médica
Servicio
Centre François Baclesse
Esch-sur-Alzette, LuxemburgoPublicacións en colaboración con investigadores/as de Centre François Baclesse (5)
2023
2017
-
Prospective validation of a lymphocyte infiltration prognostic test in stage III colon cancer patients treated with adjuvant FOLFOX
European Journal of Cancer, Vol. 82, pp. 16-24
2015
-
BIM and mTOR expression levels predict outcome to erlotinib in EGFR-mutant non-small-cell lung cancer
Scientific Reports, Vol. 5
2014
-
The impact of EGFR T790M mutations and BIM mRNA expression on outcome in patients with EGFR-Mutant NSCLC treated with erlotinib or chemotherapy in the randomized phase III EURTAC trial
Clinical Cancer Research, Vol. 20, Núm. 7, pp. 2001-2010